Tretazicar Terminated Phase 2 Trials for Hepatocellular Carcinoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00746590Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma